Cargando…
Relapse of Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine
Autores principales: | Komaba, Hirotaka, Wada, Takehiko, Fukagawa, Masafumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the National Kidney Foundation, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137360/ https://www.ncbi.nlm.nih.gov/pubmed/34023417 http://dx.doi.org/10.1053/j.ajkd.2021.05.006 |
Ejemplares similares
-
An Additional Case of Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine
por: Maas, Rutger J., et al.
Publicado: (2021) -
Focal segmental glomerulosclerosis following the Pfizer-BioNTech COVID-19 vaccine
por: Lim, Cho A, et al.
Publicado: (2022) -
Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine
por: Lebedev, Larissa, et al.
Publicado: (2021) -
Minimal risk of GBS relapse after Pfizer-BioNTech COVID-19 vaccination
Publicado: (2021) -
Minimal change disease with thrombotic microangiopathy following the Pfizer-BioNTech COVID-19 vaccine
por: Tanaka, Fumika, et al.
Publicado: (2021)